Premier Health of America Inc
XTSX:PHA

Watchlist Manager
Premier Health of America Inc Logo
Premier Health of America Inc
XTSX:PHA
Watchlist
Price: 0.02 CAD
Market Cap: CA$1.1m

Wall Street
Price Targets

PHA Price Targets Summary
Premier Health of America Inc

There are no price targets for PHA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Premier Health of America Inc Competitors:
Price Targets
YUMC
Yum China Holdings Inc
31% Upside
BMRN
Biomarin Pharmaceutical Inc
69% Upside
BLFS
BioLife Solutions Inc
56% Upside
VNET
Vianet Group PLC
237% Upside

Revenue
Forecast

38% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
38% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 5 years the compound annual growth rate for Premier Health of America Inc's revenue is 38%. The projected CAGR for the next 2 years is 18%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHA's stock price target?
Not Available

PHA doesn't have any price targets made by Wall Street professionals.

What is Premier Health of America Inc's Revenue forecast?
Projected CAGR
18%

For the last 5 years the compound annual growth rate for Premier Health of America Inc's revenue is 38%. The projected CAGR for the next 2 years is 18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett